Literature DB >> 14751035

Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.

Vahab Fatourechi1, George B Bartley, Guiti Z Eghbali-Fatourechi, Claudia C Powell, Debra D F Ahmed, James A Garrity.   

Abstract

It is generally considered that thyroid dermopathy and acropachy almost always occur with Graves' ophthalmopathy and that these two extrathyroidal manifestations are indicators of severe autoimmune disease and hence of more severe ophthalmopathy. However, documentation of these anecdotal impressions is needed. We assessed the presence of optic neuropathy and frequency of orbital decompression in 2 referral cohorts: 40 patients with acropachy and dermopathy (acropachy group) and 138 patients with Graves' dermopathy and no acropachy (dermopathy group). We compared those cohorts with a cohort of 114 patients who had ophthalmopathy without dermopathy and acropachy (control group). We considered optic neuropathy and the need for orbital decompression to be indicators of severe Graves' ophthalmopathy. The frequency of orbital decompression was significantly higher in the dermopathy group than in the control group (odds ratio, 3.55) and even higher in the acropachy group (odds ratios: 20.68 for acropachy group compared with control group; 5.83 for acropachy group compared with dermopathy group). The same trend occurred with optic neuropathy but was not statistically significant (alpha = 0.05; p = 0.07). Five patients were exceptions: they had definite Graves' dermopathy without clinically obvious ophthalmopathy. In conclusion, dermopathy and acropachy appear to be markers of severe ophthalmopathy. Occasionally, however, Graves' dermopathy occurs without clinical ophthalmopathy.

Entities:  

Mesh:

Year:  2003        PMID: 14751035     DOI: 10.1089/10507250360731541

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

Review 1.  Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.

Authors:  James A Garrity; Rebecca S Bahn
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

2.  Graves' dermopathy and acropachy.

Authors:  Takafumi Taguchi; Hideki Nakajima; Yoshio Terada
Journal:  Endocrine       Date:  2014-08-20       Impact factor: 3.633

3.  Elephantiatic dermopathy.

Authors:  Paul Madaj; Laron McPhaul; Andrew G Gianoukakis
Journal:  Int J Dermatol       Date:  2012-03-14       Impact factor: 2.736

4.  Update on the medical treatment of Graves' ophthalmopathy.

Authors:  Gregory J Griepentrog; James A Garrity
Journal:  Int J Gen Med       Date:  2009-12-29

Review 5.  Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors:  Luigi Bartalena; Vahab Fatourechi
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

6.  Prevalence and risk factors for thyroid eye disease among Korean dysthyroid patients.

Authors:  Kyung In Woo; Yoon-Duck Kim; Sang Yeul Lee
Journal:  Korean J Ophthalmol       Date:  2013-11-15

7.  Clinical Imaging Features of Thyroid Acropachy.

Authors:  Takafumi Taguchi
Journal:  Intern Med       Date:  2021-07-30       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.